It's interesting isn't it. This was planned and executed strategy that, on the surface of it risks alienating all of their shareholders except the new sophs that participated in the raise. Why would any board deliberately do this? And why wouldn't the sophs want to get the placement done before the interim trial results so they could cash in on the news?
The only reason I can think of is that a more crucial announcement is to follow, and that the one-day spike they effectively snuffed out is small fry compared to what that next major announcement will do the SP.
A $1B U.S. licensing deal perhaps?
It's interesting isn't it. This was planned and executed...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $219.8M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 38.8¢ | $2.721M | 6.715M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 342722 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 190990 | 3 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
40.3¢ |
Change
0.010 ( 2.84 %) |
||||
| Open | High | Low | Volume | ||
| 39.5¢ | 41.5¢ | 39.0¢ | 3495761 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| DXB (ASX) Chart |